Literature DB >> 16377642

Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins).

Lei Tang1, Sabine Breinig, Linda Stith, Adele Mischel, Justin Tannir, Bashkim Kokona, Robert Fairman, Eileen K Jaffe.   

Abstract

Porphobilinogen synthase (PBGS) is an obligate oligomer that can exist in functionally distinct quaternary states of different stoichiometries, which are called morpheeins. The morpheein concept describes an ensemble of quaternary structure isoforms wherein different structures of the monomer dictate different multiplicities of the oligomer (Jaffe, E. K. (2005) Trends Biochem. Sci. 30, 490-497). Human PBGS assembles into long-lived morpheeins and has been shown to be capable of forming either a high activity octamer or a low activity hexamer (Breinig, S., Kervinen, J., Stith, L., Wasson, A. S., Fairman, R., Wlodawer, A., Zdanov, A., and Jaffe, E. K. (2003) Nat. Struct. Biol. 10, 757-763). All PBGS monomers contain an alphabeta-barrel domain and an N-terminal arm domain. The N-terminal arm structure varies among PBGS morpheeins, and the spatial relationship between the arm and the barrel dictates the different quaternary assemblies. We have analyzed the structures of human PBGS morpheeins for key interactions that would be predicted to affect the oligomeric assembly. Examples of individual mutations that shift assembly of human PBGS away from the native octamer are R240A and W19A. The alternate morpheeins of human PBGS variants R240A and W19A are chromatographically separable from each other and kinetically distinct; their structure and dynamics have been characterized by native gel electrophoresis, dynamic light scattering, and analytical ultracentrifugation. R240A assembles into a metastable hexamer, which can undergo a reversible conversion to the octamer in the presence of substrate. The metastable nature of the R240A hexamer supports the hypothesis that octameric and hexameric morpheeins of PBGS are very close in energy. W19A assembles into a mixture of dimers, which appear to be stable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377642     DOI: 10.1074/jbc.M511134200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

2.  Expanding the Concepts in Protein Structure-Function Relationships and Enzyme Kinetics: Teaching using Morpheeins.

Authors:  Sarah H Lawrence; Eileen K Jaffe
Journal:  Biochem Mol Biol Educ       Date:  2008       Impact factor: 1.160

3.  Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.

Authors:  Bashkim Kokona; Daniel J Rigotti; Andrew S Wasson; Sarah H Lawrence; Eileen K Jaffe; Robert Fairman
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

4.  Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation.

Authors:  Eileen K Jaffe; Dhanasekaran Shanmugam; Anna Gardberg; Shellie Dieterich; Banumathi Sankaran; Lance J Stewart; Peter J Myler; David S Roos
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

5.  The morpheein model of allostery: evaluating proteins as potential morpheeins.

Authors:  Eileen K Jaffe; Sarah H Lawrence
Journal:  Methods Mol Biol       Date:  2012

Review 6.  Allostery and the dynamic oligomerization of porphobilinogen synthase.

Authors:  Eileen K Jaffe; Sarah H Lawrence
Journal:  Arch Biochem Biophys       Date:  2011-10-19       Impact factor: 4.013

Review 7.  Dynamic dissociating homo-oligomers and the control of protein function.

Authors:  Trevor Selwood; Eileen K Jaffe
Journal:  Arch Biochem Biophys       Date:  2011-12-13       Impact factor: 4.013

8.  Pseudomonas aeruginosa porphobilinogen synthase assembly state regulators: hit discovery and initial SAR studies.

Authors:  Allen B Reitz; Ursula D Ramirez; Linda Stith; Yanming Du; Garry R Smith; Eileen K Jaffe
Journal:  ARKIVOC       Date:  2010-06       Impact factor: 1.140

9.  MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY.

Authors:  Eileen K Jaffe
Journal:  Open Conf Proc J       Date:  2010

10.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.